CORTICOSTEROID-SPARING EFFECTS OF USTEKINUMAB THERAPY FOR ULCERATIVE COLITIS THROUGH 4 YEARS: UNIFI LONG-TERM EXTENSION

Ramesh P. Arasaradnam  1     Ellen J. Scherl  2     David Rowbotham  3     Silvio Danese  4     William Sandborn  5     Ye Miao  6     Hongyan Zhang  6     Remo Panaccione  7     Waqqas Afif  8     Tadakazu Hisamatsu  9     Rupert W Leong  10     Bruce E. Sands  11     Maria T. Abreu  12     Colleen W. Marano  12    
1 Warwick Medical School, University of Warwick & University Hospital Coventry, Coventry Warwickshire
2 Weill Cornell Medicine, New York Presbyterian Hospital, New York, United States
3 Auckland City Hospital, Auckland, New Zealand
4 Vita-Salute San Raffaele University - IRCCS San Raffaele Scientific Institute, Milan, Italy
5 University of California San Diego, San Diego, United States
6 Janssen Research & Development, LLC, Spring House
7 University of Calgary, Calgary, Canada
8 McGill University Health Center, Montreal, Canada
9 Kyorin University, Tokyo, Japan
10 Concord Hospital Dept. of Gastroenterology, Sydney, Australia
11 Icahn School of Medicine at Mount Sinai, New York, United States
12 University of Miami, Miller School of Medicine, Miami, United States

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing